The COVID-19 pandemic is one of the most serious global challenges to delivering affordable and equitable treatment to children with cancer we have witnessed in the last few decades. This Special Report aims to summarize general principles for continuing multidisciplinary care during the SARS-CoV-2 (COVID-19) pandemic. With contributions from the leadership of the International Society for Pediatric Oncology (SIOP), Children's Oncology Group (COG), St Jude Global program, and Childhood Cancer International, we have sought to provide a framework for healthcare teams caring for children with cancer during the pandemic. We anticipate the burden will fall particularly heavily on children, their families, and cancer services in low- and middle-i...
Coronavirus disease 2019 (COVID 19) is a pandemic disease that is today a global public health probl...
The worldwide coronavirus disease 19 (COVID-19) pandemic led to a critical situation in the healthca...
Data regarding real-world impact on cancer clinical research during COVID-19 are scarce. We analysed...
The COVID-19 pandemic poses an unprecedented health crisis in all socio-economic regions across the ...
Introduction Childhood cancers are a leading cause of non-communicable disease deaths for children a...
The COVID-19 pandemic quickly led to an abundance of publications and recommendations, despite a pau...
Childhood cancer represents a leading cause of death and disease burden in high income countries (HI...
Background: Childhood cancer is a highly curable disease when timely diagnosis and appropriate thera...
The COVID-19 pandemic has substantially stressed health care systems globally, subsequently reducing...
The COVID-19 pandemic has prevented the timely diagnosis and treatment of many diseases, including p...
Europe is now the epicenter of the COVID-19 outbreak. Many concerns have arisen about the management...
OBJECTIVES: Paediatric cancer is a leading cause of death for children. Children in low-income and m...
© 2020 Wiley Periodicals, Inc. A diverse panel of pediatric cancer advocates and experts, whose coll...
Introduction: Children were less severely affected by COVID-19 infection. The outcome of COVID-19 in...
Pediatric cancer patients are immunocompromised, and the risks are higher in this population. Confir...
Coronavirus disease 2019 (COVID 19) is a pandemic disease that is today a global public health probl...
The worldwide coronavirus disease 19 (COVID-19) pandemic led to a critical situation in the healthca...
Data regarding real-world impact on cancer clinical research during COVID-19 are scarce. We analysed...
The COVID-19 pandemic poses an unprecedented health crisis in all socio-economic regions across the ...
Introduction Childhood cancers are a leading cause of non-communicable disease deaths for children a...
The COVID-19 pandemic quickly led to an abundance of publications and recommendations, despite a pau...
Childhood cancer represents a leading cause of death and disease burden in high income countries (HI...
Background: Childhood cancer is a highly curable disease when timely diagnosis and appropriate thera...
The COVID-19 pandemic has substantially stressed health care systems globally, subsequently reducing...
The COVID-19 pandemic has prevented the timely diagnosis and treatment of many diseases, including p...
Europe is now the epicenter of the COVID-19 outbreak. Many concerns have arisen about the management...
OBJECTIVES: Paediatric cancer is a leading cause of death for children. Children in low-income and m...
© 2020 Wiley Periodicals, Inc. A diverse panel of pediatric cancer advocates and experts, whose coll...
Introduction: Children were less severely affected by COVID-19 infection. The outcome of COVID-19 in...
Pediatric cancer patients are immunocompromised, and the risks are higher in this population. Confir...
Coronavirus disease 2019 (COVID 19) is a pandemic disease that is today a global public health probl...
The worldwide coronavirus disease 19 (COVID-19) pandemic led to a critical situation in the healthca...
Data regarding real-world impact on cancer clinical research during COVID-19 are scarce. We analysed...